SK Capital sells Noramco assets to Siegfried
Keeps Halo Pharma to drive independent growth
Keeps Halo Pharma to drive independent growth
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
The US regulator conducted an inspection at the Amaliya manufacturing plant between April 20 and May 1, 2026
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
Subscribe To Our Newsletter & Stay Updated